| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |